Stock SNGX SOLIGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Soligenix, Inc.

Equities

SNGX

US8342235053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
0.396 USD +1.54% Intraday chart for Soligenix, Inc. +3.39% -47.70%
Apr. 25 Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa CI
Apr. 15 Sector Update: Health Care Stocks Softer Late Afternoon MT

Evolution of the average Target Price on Soligenix, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5628fdc56ba2fa9f8.8DMGBr29-7GKpV4ZgOhatQiDI0Mf52h356oslTDHN2I.ll9_d-_HrsHy4i5NtsU44nLZSgRv1FlCpPlE11KSTi-gCkVl6oyV5NDKDw~b178221f4092e444e0e6f0d4d7982372

Analyst Recommendations on Soligenix, Inc.

SOLIGENIX : Alliance Global Adjusts Price Target on Soligenix to $3.75 From $5.75, Reiterates Buy Rating MT
SOLIGENIX : B. Riley Lowers Soligenix' PT to $1.50 from $2 on Unchanged Valuation Methodology, Keeps Neutral Rating MT
SOLIGENIX : B. Riley Starts Soligenix at Buy With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.396 USD
Average target price
3.5 USD
Spread / Average Target
+783.84%
High Price Target
4 USD
Spread / Highest target
+910.10%
Low Price Target
3 USD
Spread / Lowest Target
+657.58%

Consensus detail

Consensus revision (last 18 months)

Ratings for Soligenix, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. Consensus Soligenix, Inc.